Lets say $80M on top of what they have left, to
give some safety margin. 400M @ .20c? I fear
they will try to fly by the seat of their pants again
with a much smaller raising. Depends on how
much/if the FDA allows reduction of trial numbers.
I don’t fall for the line that trial participants
treatments and monitoring will be much cheaper,
because now they have the process all worked
out from stage one. Hard to believe any news
or announcements coming from management
is not subjected to heavy spin.
Where we at?, page-295
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $103.2K | 409.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16577 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 10906 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.5¢ |
Change
0.000 ( 1.39 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 25.5¢ | 25.0¢ | 204618 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| PAR (ASX) Chart |